Proteoglycans located in basement membranes, the nanostructures underling epithelial and endothelial layers, are unique in several respects. They are usually large, elongated molecules with a collage of domains that share structural and functional homology with numerous extracellular matrix proteins, growth factors and surface receptors. They mainly carry heparan sulfate side chains and these contribute not only to storing and preserving the biological activity of various heparan sulfate-binding cytokines and growth factors, but also in presenting them in a more "active configuration" to their cognate receptors. Abnormal expression or deregulated function of these proteoglycans affect cancer and angiogenesis, and are critical for the evolution of the tumor microenvironment. This review will focus on the functional roles of the major heparan sulfate proteoglycans from basement membrane zones: perlecan, agrin and collagen XVIII, and on their roles in modulating cancer growth and angiogenesis.
INTRODUCTION
Basement membrane proteoglycans comprise a select group of high molecular-weight proteins which are almost universally decorated with heparan sulfate side chains (Yurchenco et al., 2004) . Three main basement membrane heparan sulfate proteoglycans (HSPGs) have been well characterized: perlecan, collagen type XVIII and agrin. The first identified HSPG of basement membranes was perlecan, a modular proteoglycan with homology to growth factors and proteins involved in cell growth, lipid metabolism, adhesion, and homo-and heterotypic interactions (Fuki et al., 2000; Hassell et al., 2003; Iozzo, 1998) . Collagen XVIII is a hybrid collagen/proteoglycan and a member of the multiplexin gene family together with the closely related collagen XV, which bears chondroitin sulfate side chains instead of HS chains (Oh et al., 1994a) . Finally, the HSPG agrin represents an abundant constituent of most basement membranes and possesses a specialized function at the neuromuscular junction (Bezakova and Rüegg, 2003) . The genes encoding these three HSPG protein cores are highly conserved and carry disparate biological functions, ranging from maintenance of basement membrane homeostasis to modulation of growth factor activity and angiogenesis. Moreover, some of these gene products are expressed in avascular tissues, such as cartilage, and in musculoskeletal and nervous tissues, where they modulate neuronal transmission and ocular development. Defects in some of these genes cause various human inherited disorders and often the disease phenotypes correlate well with those of mutant mice, flies and worms.
An emerging body of work supports the concept that these HSPGs have a dual function as pro-and anti-angiogenic factors (Iozzo and San Antonio, 2001) . Via the HS chains, these proteoglycans can stimulate angiogenic signaling by sequestering, protecting and concentrating HS-binding growth factors such as FGF2, VEGF and PDGF, through which the HSGPgrowth factor complex may be presented in a "biologically active" form to the cognate receptors. Alternatively, via proteolytic processing of their C-termini, these gene products can release powerful angiostatic fragments such as endostatin and endorepellin which can act in a paracrine function on sprouting endothelial cells, either locally or distantly.
This review will focus primarily on these three basement membrane HSPGs and will critically assess recent information related to their roles in regulating cancer growth and angiogenesis.
Perlecan, a multimodular and multifunctional proteoglycan
The designation for "perlecan" originates from studies using rotary shadowing electron microscopy which have shown a tortuous linear polymer with interspersed globular domains resembling a "string of pearls" (Hassell et al., 2003) . Perlecan is a modular HSPG and is one of the largest single-chain polypeptides found in vertebrate and invertebrate animals (Iozzo, 1994; 1998; Iozzo et al., 1994; Whitelock et al., 2008) . The five modules of perlecan are collated from protein units evolutionarily related to molecules involved in cell growth, lipid uptake and metabolism, intercellular interactions and adhesion (Fig. 1) . The perlecan protein core is ~470 kDa and, together with several Olinked oligosaccharides and as many as four HS chains, three in domain I and one potential in domain V (Hassell et al., 2003) , it can reach a molecular mass of over 800 kDa. An intriguing question about perlecan's evolutionary biology which has been recently raised (Farach-Carson and Carson, 2007) is: What is the advantage of linking 46 protein modules into a gigantic polypeptide over the synthesis of individual protomers? Perhaps, the answer lies in the generation of a protein scaffold, such as a long heterofunctional protein. The large size of perlecan's protein core which spans ~200 nm in length, together with the three HS chains which could span an additional 60 nm in three dimensions, make perlecan an appropriate linker between extracellular matrix and cell surface receptors or complexes of receptors. The various modules of perlecan and the HS chains have a large repertoire of molecular interactions that include association with numerous HS-binding growth factors such as FGF2, FGF7, VEGF and PDGF, and other proteins which are constituents of basement membranes (Aviezer et al., 1994; Iozzo, 2005; Mongiat et al., 2000; 2001; Whitelock and Iozzo, 2005) . Perlecan inhibits thrombosis (Nugent et al., 2000) , and exhibits adhesive (Whitelock et al., 1999) or anti-adhesive (Klein et al., 1995) properties presumably by differentially affecting surface receptors such as α2β1 integrin (Bix and Iozzo, 2005) .
Our characterization of zebrafish perlecan provided the first genetic evidence linking perlecan function to developmental angiogenesis (Zoeller et al., 2008) . By morpholino-mediated perlecan knockdown we found that angiogenic blood vessel development of the intersegmental and sub-intestinal vessels was largely inhibited in the absence of perlecan. Vasculogenesis, the formation of the dorsal aorta and posterior cardinal vein, was observed to proceed normally, suggesting perlecan was only required for angiogenesis. A closer analysis revealed that the morphant vessels were non-functional, as evidenced by the lack of circulatory flow. Combined, these results suggested that perlecan functions at multiple levels during the angiogenic cascade, possibly influencing endothelial cell migration or proliferation and the events of lumen formation. The exact nature of perlecan function within these contexts is the current focus of our investigation.
Preceding the examination of zebrafish perlecan, analysis of murine perlecan expression in wild-type (Handler et al., 1997) and perlecan-deficient animals (Arikawa-Hirasawa et al., 1999; Costell et al., 1999 ) also supported a role for perlecan in vascular development. The perlecan-null mouse exhibits embryonic lethality associated with hemorrhage in the pericardial cavity or respiratory failure, and vessel modeling defects in the development of the great arteries and coronary artery pattern (Costell et al., 2002; González-Iriarte et al., 2003) . The perlecan-null mouse does not exhibit any striking defects in developmental angiogenesis, a surprising observation given the widespread distribution of perlecan throughout the vascular basement membrane. Such observations brought to light the possibility of compensatory mechanisms which, perhaps mediated by collagen XVIII, could counter the lack of perlecan. The generation of a double knockout mouse (collagen XVIII and perlecan HS deficient) (Rossi et al., 2003) , which exhibits compounded ocular defects compared to either alone, supports such principles. Furthermore, analysis of the perlecan HS-deficient mouse alone revealed altered growth factor modulation in numerous settings linked to angiogenesis (Tran et al., 2004; Zhou et al., 2004) .
Beyond development, the role of perlecan has been defined within the context of tumor growth and angiogenesis (Cohen et al., 1994; Iozzo et al., 1997; Mathiak et al., 1997) . Structurally, perlecan co-localizes and supports new tumor blood vessel development (Iozzo et al., 1994) . In addition to a structural role, perlecan serves a signaling function via the HS chains which are capable of binding and modulating numerous growth factors involved with angiogenesis. Perhaps the best studied are members of the FGF family, including the pro-angiogenic FGF2 (Nugent and Iozzo, 2000) . Perlecan binds FGF2 via HS, promotes receptor activation and ultimately downstream signaling which supports mitogenesis and angiogenesis (Iozzo and Murdoch, 1996) . Targeted deletion of perlecan-specific HS reduces matrix binding of FGF2 and results in enhanced smooth muscle cell proliferation (Tran et al., 2004) , while the lack of HS inhibits wound healing and FGF2-induced angiogenesis and tumor growth (Zhou et al., 2004) . Similarly, targeted knockdown of perlecan reduced growth factor response in prostate cancer cells (Savoré et al., 2005) as evidenced by decreased tumor growth and angiogenesis. Accordingly, these findings were similar to those observed in additional tumor cell lines (Adatia et al., 1998; Aviezer et al., 1997; Sharma et al., 1998) and supported by comparable observations in colon cancer cells harboring a somatic mutation in perlecan (Ghiselli et al., 2001) . Taken together, these results implicate perlecan as a crucial component of growth factor regulation. The HSPG perlecan could be envisioned to coordinate a matrix gradient, protect growth factors from the environment, concentrate and/or present ligand to receptor, all within a context-specific fashion.
A recent report has further established the role of perlecan HS and tumor angiogenesis, with specific reference to VEGF-VEGFR2 modulation. Using hepatoblastoma xenografts treated with anti-VEGFR therapy, vessel recovery over time was associated with an increase in perlecan and heparanase expression around tumor vessels (Kadenhe-Chiweshe et al., 2008) . Accordingly, the potential heparanase-mediated release of HS-bound VEGF (Reiland et al., 2004) or proteolytic protein core processing liberating growth factor-bound fragments (Whitelock et al., 1996) , was found to support VEGFR2 activation and downstream survival signaling (Kadenhe-Chiweshe et al., 2008) .
Collagen XVIII, a hybrid proteoglycan
Collagen type XVIII possesses features of collagens and proteoglycans and represents a member of the "multiplexin" family (Marneros and Olsen, 2005) . The multiplexins, which include collagens XV and XVIII, are characterized by multiple triplehelix domains with interruptions (Oh et al., 1994a) . Structurally, collagen type XVIII (Fig. 1) consists of ten interrupted collagenous domains, flanked by noncollagenous domains at the Nand C-termini. Collagen XVIII also harbors three Ser-Gly consensus binding sites for the attachment of HS glycosaminoglycan chains (Dong et al., 2003) and is an HSPG (Halfter et al., 1998) . Collagen XVIII expression can be detected throughout the vascular and epithelial basement membranes of human and mouse tissues, with an overall distribution similar to that of perlecan (Marneros and Olsen, 2005) .
Collagen XVIII is a homotrimer comprised of three identical α1 chains. The human `liNU^N gene, localized to chromosome 21 and spanning 105 kb, comprises 43 exons (Oh et al., 1994b) which generate three protein variants derived from alternative promoter usage and splicing events (Elamaa et al., 2003; Saarela et al., 1998; Suzuki et al., 2002) . The human and mouse α1 (XVIII) collagen amino acid sequences exhibit 79% identity (Rehn et al., 1994) and an overall general conservation. Accordingly, the function of collagen XVIII has been explored through the analysis of a murine collagen XVIII knockout. Characterization of the `çäNU~N JLJ mouse revealed that collagen XVIII is not required for viability or fertility but is essential for proper eye development (Fukai et al., 2002) . Basement membrane thickening in a sub-line of `çäNU~N JLJ= mice also suggests a role for collagen XVIII during maintenance of the basement
